Trial intelligence / Profile preview

Integrated Chinese and Western medicine for diabetic peripheral neuropathy

ChiCTR2000038848Phase 4Not yet recruiting

Sponsor
Renji Hospital
Start
Oct 2020
Countries
1
01

Overview

Phase 4, randomised, open-label trial of Wu-Zhu-Yu Decoction in diabetic polyneuropathy (DPN) (2 arms), sponsored by Renji Hospital. Primary endpoints: Modified neurological disability score, Michigan Neuropathy Screening Instrument and 1 more. Planned start Oct 2020; status: not yet recruiting.

02

Drugs

Wu-Zhu-Yu Decoction
03

Conditions

diabetic polyneuropathy (DPN)

Beyond the preview

Go deeper on ChiCTR2000038848.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000038848.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call